by Elizabeth Kissling | Dec 13, 2009 | Advertising, Law/Legal, Media, Menopause
There’s a pretty good essay in this weekend’s New York Times (online here Saturday, in print Sunday in the Business section) about how hard Big Pharma has worked to market menopause as an estrogen deficiency disease. In addition to discussion of...
by Elizabeth Kissling | Dec 11, 2009 | Girls, Health Care, Law/Legal, New Research, Pharmaceutical
Today I want to point to two important articles about women’s health from our friends at Women’s eNews: Yesterday, they published a story about Myriad Genetics and their firm grasp on the patents for diagnostics tests for BRCA1 and BRCA2 genes, which are...
by Elizabeth Kissling | Dec 9, 2009 | FemCare, New Research
Toxic shock syndrome is a potentially deadly complication of bacterial infection, resulting from Staphylococcus aureus (staph) bacteria. It has been associated with the use of super-absorbent tampons (most notably, the infamous Rely brand in 1980), but other risk...
by Elizabeth Kissling | Dec 8, 2009 | Meta
It has come to my attention that there have been some problems with the automated email subscription feature of this site. If you have tried in the past to sign up for email notification of updates to re:Cycling and were unsuccessful, please try again. I think I have...
by Elizabeth Kissling | Dec 8, 2009 | Law/Legal, Menopause, Pharmaceutical
Here’s one way that Canada shows some concern for risks to women’s health: the owner of a New Brunswick health food store was fined $7500 for smuggling a progesterone-laced cream from the U.S. The cream, called Aim Renewed Balance, is purported “to...
